Evidence map›Paper›PMID 40160033›Full record

ArticleACS nano2025

Controlled Sensing of User-Defined Aptamer-Based Targets Using Scanning Ionic Conductance Spectroscopy.

Helena Miljkovic, Lely Feletti, Gordanna Pistoletti Blanchet, Marcos Penedo, Zahra Ayar, Barney Drake, Alexandre Kuhn, Wayne Yang, Georg E Fantner, Aleksandra Radenovic

Abstract read
In one paragraph

Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Helena MiljkovicLaboratory of Nanoscale Biology (LBEN), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.ORCID 0000-0002-5211-040X
Lely FelettiLaboratory of Nanoscale Biology (LBEN), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
Gordanna Pistoletti BlanchetLaboratory of Molecular Biology, Institute of Life Sciences, School of Engineering, HES-SO Valais-Wallis, 1950 Sion, Switzerland.
Marcos PenedoLaboratory for Bio and Nano Instrumentation (LBNI), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
Zahra AyarLaboratory for Bio and Nano Instrumentation (LBNI), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
Barney DrakeLaboratory for Bio and Nano Instrumentation (LBNI), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
Alexandre KuhnLaboratory of Molecular Biology, Institute of Life Sciences, School of Engineering, HES-SO Valais-Wallis, 1950 Sion, Switzerland.ORCID 0000-0003-3839-5282
Wayne YangLaboratory of Nanoscale Biology (LBEN), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.ORCID 0000-0001-8623-5027
Georg E FantnerLaboratory for Bio and Nano Instrumentation (LBNI), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.ORCID 0000-0001-5889-3022
Aleksandra RadenovicLaboratory of Nanoscale Biology (LBEN), Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.ORCID 0000-0001-8194-2785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid-state nanopores offer the possibility of detecting disease biomarkers in early diagnostic applications. Standard approaches harness fingerprinting, where protein targets are bound to DNA carriers and detected in free translocation with a solid-state nanopore. However, they suffer from several drawbacks, including uncontrolled fast translocations, which lead to low detection accuracy and a low signal-to-noise ratio (SNR). This has hampered their application in clinical settings. Here, we propose a nanopore-based system capable of sensing selected molecules of interest from biological fluids by harnessing programmable aptamer sequences attached to DNA carrier systems that are tethered to glass surfaces. This allows for spatial and velocity control over translocation in the

Indexed as

Aptamers, NucleotideBiosensing TechniquesNanoporesSpectrum AnalysisDNAAptamers, NucleotideDNAaptamerproteinSICSsingle molecule detectionsolid-state nanopore

Identifiers

PMID40160033
PMCPMC11984302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.